T1	tradename 188 188	
T2	tradename 251 269	ELIGARD. ELIGARD
T3	activeingredient 271 290	leuprolide acetate)
T4	routeofadministration 306 318	subcutaneous
T5	fdaapprovaldate 352 356	2002
T6	tradename 591 591	
T7	indication 685 709	advanced prostate cancer
T8	dose 794 800	7.5 mg
T9	routeofadministration 801 815	subcutaneously
T10	frequency 816 827	every month
T11	dose 842 849	22.5 mg
T12	routeofadministration 850 864	subcutaneously
T13	frequency 865 879	every 3 months
T14	dose 894 899	30 mg
T15	routeofadministration 900 914	subcutaneously
T16	frequency 915 929	every 4 months
T17	dose 944 949	45 mg
T18	routeofadministration 950 964	subcutaneously
T19	frequency 965 979	every 6 months
T20	dose 1086 1092	7.5 mg
T21	dose 1130 1137	22.5 mg
T22	dose 1175 1180	30 mg
T23	dose 1218 1223	45 mg
T24	tradename 1398 1405	ELIGARD
T25	adversereaction 1449 1461	Tumor Flare;
T26	adversereaction 1845 1858	Hyperglycemia
T27	adversereaction 1863 1886	diabetes: Hyperglycemia
T28	adversereaction 1923 1931	diabetes
T29	adversereaction 2121 2164	myocardial infarction, sudden cardiac death
T30	adversereaction 2169 2175	stroke
T31	adversereaction 2587 2624	Malaise, fatigue, hot flashes/sweats,
T32	adversereaction 2629 2648	testicular atrophy.
T33	adversereaction 2729 2751	decreased bone density
T34	adversereaction 2770 2788	pituitary apoplexy
T35	company 2867 2895	TOLMAR Pharmaceuticals, Inc.
T36	tradename 3058 3065	ELIGARD
T37	adversereaction 3523 3534	Tumor Flare
T38	adversereaction 3562 3575	Hyperglycemia
T39	adversereaction 3580 3588	Diabetes
T40	tradename 4532 4539	ELIGARD
T41	indication 4585 4610	advanced prostate cancer.
T42	tradename 4741 4748	ELIGARD
T43	activeingredient 4815 4833	leuprolide acetate
T44	activeingredient 4939 4957	leuprolide acetate
T45	tradename 5007 5014	ELIGARD
T46	tradename 5206 5213	ELIGARD
T47	tradename 5947 5954	ELIGARD
T48	tradename 5981 5988	ELIGARD
T49	activeingredient 6182 6200	leuprolide acetate
T50	activeingredient 7195 7214	leuprolide acetate.
T51	tradename 7453 7460	ELIGARD
T52	tradename 7498 7505	ELIGARD
T53	tradename 8189 8196	ELIGARD
T54	tradename 8780 8787	ELIGARD
T55	tradename 10588 10595	ELIGARD
T56	tradename 11302 11309	ELIGARD
T57	activeingredient 11341 11359	leuprolide acetate
T58	activeingredient 11727 11746	leuprolide acetate.
T59	tradename 11766 11773	ELIGARD
T60	tradename 11818 11825	ELIGARD
T61	tradename 11848 11855	ELIGARD
T62	adversereaction 12129 12145	Hypersensitivity
T63	tradename 12146 12153	ELIGARD
T64	adversereaction 12190 12206	hypersensitivity
T65	tradename 12265 12272	ELIGARD
T66	adversereaction 12275 12297	Anaphylactic reactions
T67	tradename 12394 12401	ELIGARD
T68	tradename 12504 12511	ELIGARD
T69	tradename 12654 12661	ELIGARD
T70	adversereaction 12923 12934	Tumor Flare
T71	tradename 12935 12942	ELIGARD
T72	dose 12943 12964	7.5 mg 22.5 mg 30 mg,
T73	tradename 13095 13102	ELIGARD
T74	dose 13103 13108	45 mg
T75	adversereaction 13351 13384	bone pain, neuropathy, hematuria,
T76	adversereaction 13388 13415	bladder outlet obstruction.
T77	adversereaction 13555 13575	ureteral obstruction
T78	adversereaction 13583 13607	spinal cord compression,
T79	indication 13729 13753	advanced prostate cancer
T80	adversereaction 13926 13949	spinal cord compression
T81	adversereaction 13953 13973	ureteral obstruction
T82	tradename 14082 14089	ELIGARD
T83	tradename 14542 14549	ELIGARD
T84	dose 14550 14557	7.5 mg.
T85	tradename 14711 14718	ELIGARD
T86	dose 14719 14727	22.5 mg.
T87	tradename 14769 14776	ELIGARD
T88	dose 14777 14783	30 mg,
T89	tradename 14889 14896	ELIGARD
T90	dose 14897 14903	45 mg,
T91	activeingredient 15259 15277	leuprolide acetate
T92	adversereaction 15479 15492	Hyperglycemia
T93	adversereaction 15497 15519	Diabetes Hyperglycemia
T94	adversereaction 15556 15564	diabetes
T95	adversereaction 15616 15629	Hyperglycemia
T96	adversereaction 15659 15676	diabetes mellitus
T97	adversereaction 15898 15911	hyperglycemia
T98	adversereaction 15915 15924	diabetes.
T99	adversereaction 15930 15953	Cardiovascular Diseases
T100	adversereaction 15983 16026	myocardial infarction, sudden cardiac death
T101	adversereaction 16031 16037	stroke
T102	adversereaction 16404 16426	cardiovascular disease
T103	tradename 17126 17133	ELIGARD
T104	indication 17204 17229	advanced prostate cancer.
T105	tradename 17258 17265	ELIGARD
T106	dose 17266 17272	7.5 mg
T107	tradename 17331 17338	ELIGARD
T108	dose 18283 18309	7.5 mg 22.5 mg 30 mg 45 mg
T109	frequency 18412 18424	every month
T110	duration 18425 18439	up to 6 months
T111	frequency 18453 18467	every 3 months
T112	duration 18468 18482	up to 6 months
T113	frequency 18496 18510	every 4 months
T114	duration 18511 18525	up to 8 months
T115	frequency 18539 18553	every 6 months
T116	duration 18554 18569	up to 12 months
T117	adversereaction 19147 19155	Bruising
T118	tradename 19506 19513	ELIGARD
T119	dose 19514 19522	22.5 mg.
T120	tradename 19903 19910	ELIGARD
T121	dose 19911 19917	30 mg.
T122	tradename 19944 19951	ELIGARD
T123	dose 19952 19958	30 mg,
T124	tradename 20182 20189	ELIGARD
T125	dose 20190 20196	45 mg.
T126	tradename 20339 20346	ELIGARD
T127	dose 20347 20353	45 mg.
T128	tradename 20594 20601	ELIGARD
T129	indication 20713 20740	metastatic prostate cancer.
T130	tradename 20913 20920	ELIGARD
T131	dose 21183 21216	7.5 mg 7.5 mg 22.5 mg 30 mg 45 mg
T132	frequency 21329 21340	every month
T133	duration 21341 21355	up to 6 months
T134	frequency 21414 21428	every 3 months
T135	duration 21429 21443	up to 6 months
T136	frequency 21457 21471	every 4 months
T137	duration 21472 21486	up to 8 months
T138	frequency 21500 21514	every 6 months
T139	duration 21515 21530	up to 12 months
T140	adversereaction 21592 21599	Malaise
T141	adversereaction 21604 21611	Fatigue
T142	adversereaction 21655 21663	Weakness
T143	adversereaction 21689 21698	Dizziness
T144	adversereaction 21726 21744	Hot flashes/sweats
T145	adversereaction 21823 21840	Urinary frequency
T146	adversereaction 21859 21867	Nocturia
T147	adversereaction 21895 21901	Nausea
T148	adversereaction 21920 21943	Gastroenteritis/colitis
T149	adversereaction 21959 21967	Pruritis
T150	adversereaction 21977 21987	Clamminess
T151	adversereaction 21999 22011	Night sweats
T152	adversereaction 22033 22041	Alopecia
T153	adversereaction 22067 22077	Arthralgia
T154	adversereaction 22088 22095	Myalgia
T155	adversereaction 22114 22126	Pain in limb
T156	adversereaction 22150 22168	Testicular atrophy
T157	adversereaction 22199 22211	Gynecomastia
T158	adversereaction 22233 22248	Testicular pain
T159	adversereaction 22270 22286	Decreased libido
T160	tradename 22406 22413	ELIGARD
T161	dose 22414 22421	7.5 mg,
T162	adversereaction 22436 22454	hot flashes/sweats
T163	tradename 22620 22627	ELIGARD
T164	dose 22628 22636	22.5 mg,
T165	adversereaction 22651 22669	hot flashes/sweats
T166	tradename 22834 22841	ELIGARD
T167	dose 22842 22848	30 mg,
T168	adversereaction 22863 22872	hot flash
T169	tradename 23039 23046	ELIGARD
T170	dose 23047 23053	45 mg,
T171	adversereaction 23068 23077	hot flash
T172	tradename 23338 23345	ELIGARD
T173	adversereaction 23527 23583	Sweating, insomnia, syncope, rigors, weakness, lethargy
T174	adversereaction 23601 23636	Flatulence, constipation, dyspepsia
T175	adversereaction 23649 23707	Decreased red blood cell count, hematocrit and hemoglobin
T176	adversereaction 23718 23729	Weight gain
T177	adversereaction 23746 23802	Tremor, backache, joint pain, muscle atrophy, limb pain
T178	adversereaction 23811 23862	Disturbance of smell and taste, depression, vertigo
T179	adversereaction 23875 23912	Insomnia, depression, loss of libido*
T180	adversereaction 23927 24104	Difficulties with urination, pain on urination, scanty urination, bladder spasm, blood in urine, urinary retention, urinary urgency, incontinence, nocturia, nocturia aggravated
T181	adversereaction 24121 24157	Testicular soreness/pain, impotence*
T182	adversereaction 24191 24204	gynecomastia*
T183	adversereaction 24206 24233	breast soreness/tenderness*
T184	adversereaction 24236 24255	testicular atrophy*
T185	adversereaction 24257 24295	erectile dysfunction, penile disorder*
T186	adversereaction 24297 24315	reduced penis size
T187	adversereaction 24322 24357	Alopecia, clamminess, night sweats*
T188	adversereaction 24359 24378	sweating increased*
T189	adversereaction 24389 24414	Hypertension, hypotension
T190	adversereaction 24486 24510	Changes in Bone Density:
T191	adversereaction 24849 24867	pituitary apoplexy
T192	adversereaction 25057 25074	pituitary adenoma
T193	adversereaction 25108 25126	pituitary apoplexy
T194	adversereaction 25225 25243	pituitary apoplexy
T195	adversereaction 25261 25343	sudden headache, vomiting, visual changes, ophthalmoplegia, altered mental status,
T196	adversereaction 25358 25382	cardiovascular collapse.
T197	adversereaction 25431 25442	Convulsions
T198	tradename 25721 25728	ELIGARD
T199	tradename 25850 25857	ELIGARD
T200	tradename 25985 25992	ELIGARD
T201	activeingredient 26348 26366	leuprolide acetate
T202	tradename 26682 26689	ELIGARD
T203	tradename 26947 26955	Eligard,
T204	tradename 27154 27161	ELIGARD
T205	frequency 27374 27379	daily
T206	routeofadministration 27380 27392	subcutaneous
T207	activeingredient 27407 27425	leuprolide acetate
T208	indication 27443 27459	prostate cancer,
T209	dose 27477 27482	20 mg
T210	frequency 27482 27486	/day
T211	duration 27497 27506	two years
T212	dose 27572 27576	1 mg
T213	frequency 27576 27580	/day
T214	tradename 27604 27611	ELIGARD
T215	nanoparticle 27625 27641	polymeric matrix
T216	activeingredient 27657 27676	leuprolide acetate,
T217	routeofadministration 27697 27709	subcutaneous
T218	activeingredient 27748 27766	leuprolide acetate
T219	activeingredient 27923 27941	Leuprolide acetate
T220	tradename 28413 28420	ELIGARD
T221	tradename 28634 28641	ELIGARD
T222	routeofadministration 28658 28673	subcutaneously,
T223	activeingredient 28792 28811	leuprolide acetate.
T224	corecomposition 28907 28951	poly (DL-lactide-co-glycolide) (PLGH or PLG)
T225	inactiveingredient 29010 29039	N-methyl-2-pyrrolidone (NMP).
T226	tradename 29139 29146	ELIGARD
T227	tradename 29349 29356	ELIGARD
T228	tradename 29421 29428	ELIGARD
T229	dose 29429 29435	7.5 mg
T230	tradename 29437 29444	ELIGARD
T231	dose 29445 29452	22.5 mg
T232	tradename 29454 29461	ELIGARD
T233	dose 29462 29467	30 mg
T234	tradename 29469 29476	ELIGARD
T235	dose 29477 29482	45 mg
T236	activeingredient 29874 29892	Leuprolide acetate
T237	activeingredient 30193 30212	Leuprolide acetate,
T238	activeingredient 30457 30475	leuprolide acetate
T239	activeingredient 30637 30655	leuprolide acetate
T240	activeingredient 30983 31001	leuprolide acetate
T241	activeingredient 31266 31284	leuprolide acetate
T242	tradename 31507 31514	ELIGARD
T243	tradename 31659 31666	ELIGARD
T244	frequency 31694 31701	monthly
T245	tradename 31717 31724	ELIGARD
T246	dose 31725 31731	7.5 mg
T247	tradename 32025 32032	ELIGARD
T248	dose 32033 32040	22.5 mg
T249	tradename 32643 32650	ELIGARD
T250	dose 32651 32656	30 mg
T251	tradename 33137 33144	ELIGARD
T252	dose 33145 33150	45 mg
T253	activeingredient 33568 33586	Leuprolide acetate
T254	routeofadministration 33612 33619	orally.
T255	tradename 33654 33661	ELIGARD
T256	dose 33662 33668	7.5 mg
T257	cmax 33899 33909	25.3 ng/mL
T258	tmax 33934 33941	5 hours
T259	tradename 34207 34214	ELIGARD
T260	dose 34215 34221	7.5 mg
T261	tradename 34403 34410	ELIGARD
T262	dose 34411 34417	7.5 mg
T263	tradename 34432 34439	ELIGARD
T264	dose 34440 34447	22.5 mg
T265	tradename 34537 34544	ELIGARD
T266	dose 34545 34553	22.5 mg)
T267	tradename 35021 35028	ELIGARD
T268	dose 35029 35036	22.5 mg
T269	tradename 35087 35094	ELIGARD
T270	dose 35095 35100	30 mg
T271	tradename 35209 35216	ELIGARD
T272	dose 35217 35222	30 mg
T273	indication 35245 35269	advanced prostate cancer
T274	cmax 35379 35388	150 ng/mL
T275	tmax 35413 35422	3.3 hours
T276	tradename 35691 35698	ELIGARD
T277	dose 35699 35704	30 mg
T278	tradename 35755 35762	ELIGARD
T279	dose 35763 35768	45 mg
T280	tradename 35876 35883	ELIGARD
T281	dose 35884 35890	45 mg)
T282	cmax 36005 36027	82 ng/mL and 102 ng/mL
T283	tmax 36052 36061	4.5 hours
T284	tradename 36409 36416	ELIGARD
T285	dose 36417 36422	45 mg
T286	tradename 36839 36846	ELIGARD
T287	routeofadministration 37007 37018	intravenous
T288	volumeofdistribution 37071 37076	27 L.
T289	dose 37186 37190	1-mg
T290	clearance 37284 37293	8.34 L/h,
T291	plasmahalflife 37349 37356	3 hours
T292	tradename 37436 37443	ELIGARD
T293	activeingredient 37481 37499	leuprolide acetate
T294	activeingredient 37538 37556	leuprolide acetate
T295	tradename 37647 37654	ELIGARD
T296	tradename 38071 38078	ELIGARD
T297	dose 38080 38086	7.5 mg
T298	tradename 38087 38094	ELIGARD
T299	dose 38095 38102	22.5 mg
T300	tradename 38104 38111	ELIGARD
T301	dose 38112 38117	30 mg
T302	tradename 38119 38126	ELIGARD
T303	dose 38127 38132	45 mg
T304	tradename 38241 38248	ELIGARD
T305	activeingredient 38460 38478	leuprolide acetate
T306	dose 38682 38697	0.6 to 4 mg/kg)
T307	activeingredient 38909 38935	leuprolide acetate-induced
T308	dose 39005 39013	60 mg/kg
T309	duration 39018 39028	two years.
T310	activeingredient 39061 39079	leuprolide acetate
T311	duration 39084 39101	up to three years
T312	dose 39124 39129	10 mg
T313	frequency 39129 39133	/day
T314	duration 39142 39151	two years
T315	dose 39174 39179	20 mg
T316	frequency 39179 39183	/day
T317	tradename 39282 39289	ELIGARD
T318	activeingredient 39338 39356	leuprolide acetate
T319	tradename 39404 39411	ELIGARD
T320	dose 39412 39418	7.5 mg
T321	tradename 39583 39590	ELIGARD
T322	dose 39604 39627	7.5 mg, 22.5 mg, 30 mg,
T323	dose 39632 39638	45 mg)
T324	tradename 39949 39956	ELIGARD
T325	dose 39957 39964	7.5 mg,
T326	tradename 40140 40147	ELIGARD
T327	dose 40148 40156	22.5 mg,
T328	tradename 40465 40472	ELIGARD
T329	dose 40473 40479	30 mg,
T330	tradename 41644 41651	ELIGARD
T331	dose 41652 41658	45 mg,
T332	tradename 42188 42195	ELIGARD
T333	dose 42213 42239	7.5 mg 22.5 mg 30 mg 45 mg
T334	frequency 42616 42634	every three months
T335	frequency 42669 42686	every four months
T336	frequency 42720 42736	every six months
T337	duration 42773 42809	6 months 6 months 8 months 12 months
T338	tradename 44184 44191	ELIGARD
T339	dose 44192 44198	7.5 mg
T340	tradename 44258 44265	ELIGARD
T341	dose 44266 44273	22.5 mg
T342	tradename 44375 44382	ELIGARD
T343	dose 44383 44388	30 mg
T344	tradename 44568 44575	ELIGARD
T345	dose 44576 44581	45 mg
T346	tradename 44951 44958	ELIGARD
T347	tradename 45009 45016	ELIGARD
T348	tradename 45045 45052	ELIGARD
T349	dose 45053 45079	7.5 mg 22.5 mg 30 mg 45 mg
T350	tradename 45677 45684	ELIGARD
T351	dose 45685 45691	7.5 mg
T352	tradename 45693 45700	ELIGARD
T353	dose 45701 45708	22.5 mg
T354	tradename 45710 45717	ELIGARD
T355	dose 45718 45723	30 mg
T356	tradename 45725 45732	ELIGARD
T357	dose 45733 45738	45 mg
T358	tradename 47307 47314	ELIGARD
T359	tradename 47430 47437	ELIGARD
T360	dose 47438 47444	7.5 mg
T361	tradename 47472 47479	ELIGARD
T362	dose 47480 47487	22.5 mg
T363	tradename 47515 47522	ELIGARD
T364	dose 47523 47528	30 mg
T365	tradename 47556 47563	ELIGARD
T366	dose 47564 47569	45 mg
T367	tradename 47598 47605	ELIGARD
T368	tradename 47728 47735	ELIGARD
T369	dose 47736 47742	7.5 mg
T370	tradename 47770 47777	ELIGARD
T371	dose 47778 47785	22.5 mg
T372	tradename 47813 47820	ELIGARD
T373	dose 47821 47826	30 mg
T374	tradename 47854 47861	ELIGARD
T375	dose 47862 47867	45 mg
T376	adversereaction 48039 48051	hot flashes.
T377	adversereaction 48132 48142	bone pain,
T378	adversereaction 48153 48177	difficulty in urinating,
T379	adversereaction 48210 48218	weakness
T380	adversereaction 48222 48232	paralysis.
T381	tradename 48326 48333	ELIGARD
T382	company 48748 48759	TOLMAR Inc.
T383	company 48790 48815	TOLMAR Therapeutics, Inc.
T384	company 48858 48886	TOLMAR Pharmaceuticals, Inc.
T385	company 48918 48946	TOLMAR Pharmaceuticals, Inc.
